Systematic review shows reduced mortality and shorter hospital stays from care pathways in heart failure patients, indicating potential benefits despite variable organizational impacts.
By combining all possible results, it can be concluded that care pathways for treatment of heart failure decrease mortality rates and length of hospital stay, but no statistically significant difference was observed in the readmission rates and hospitalisation costs. However, one should be cautious with overall conclusions: what works for one organization may not work for another because of the subtle differences in processes and bottlenecks.
No takes yet. Share an insight, caveat, or question.
Kul et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: